News

Coronavirus Update: Rare blood-clotting issue dominates COVID news as Denmark scraps AstraZeneca vaccine

0

The growing concerns about a rare blood-clotting disorder that has been reported in people who received the vaccines developed by AstraZeneca PLC and Oxford University and Johnson & Johnson dominated COVID-19 news on Wednesday, with Denmark becoming the first country to fully discontinue use of the AstraZeneca jab.

The Moneyist: I’m on track to retire at 58. My fiancée is in debt and drives my old car, and I support her family. How do I ensure my son inherits my wealth after I die?

Previous article

: Kroger launches hi-tech facility as digital competition among grocers heats up

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in News